A new type of non-invasive imaging test may help prevent heart attacks. Known as Low-Dose Coronary CT Angiogram (CTA), the test uses less radiation than conventional imaging tests and may help detect heart disease certain asymptomatic patients.
Over 40000 people of Nepal are suffering from heart diseases, according to a latest report published by the Nepal Heart Foundation (NHF). Heart diseases account for 25 per cent of the total deaths in the country, the report said.
TWC Global, LLC, 530 Showers Drive, Suite 7-129, Mountain View, CA 94040, announced that it is conducting a voluntary nationwide recall of the company’s supplement products sold under the names of Axcil and Desirin.
Nearly two thirds of people across the UK are failing to eat the recommended five daily portions of fruit and vegetables – according to research released today.
While obesity has been shown to contribute to high blood pressure, heart disease and diabetes, being overweight in old age does not lead to memory problems, according to a study published September 19, 2007, in the online edition of Neurology®, the medical journal of the American Academy of Neurology.
Failing to pay attention to your vascular health could lead to potentially life-threatening conditions, including “silent” blood clots that travel through the bloodstream into the heart or lungs.
The National Kidney Disease Education Program (NKDEP), an initiative of the National Institutes of Health (NIH), has created an educational brochure tailored specifically for African Americans at risk for kidney disease.
More than 20 million adults in the United States are living with diabetes and are at increased risk of cardiovascular disease (CVD). But there are steps that they can take to reduce the complications associated with these two diseases.
A new book of pocket-charts that will help health workers to identify people at risk of heart attacks and strokes and save lives by prescribing the most appropriate treatment is published by the World Health Organization (WHO).
Researchers at the University of Texas Medical Branch at Galveston are trying to determine whether a drug already available to heart patients can also be used to delay delivery in expectant mothers with severe pre-eclampsia. If so, this groundbreaking study would give hope to hundreds of thousands of women who experience this life-threatening disorder each year.